What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Immunology, Virology, T cell, Antigen and Interleukin 21.
His Viral replication, Immune system and T-cell receptor study are his primary interests in Immunology.
His Virology study incorporates themes from Human leukocyte antigen and Major histocompatibility complex.
His Antigen research incorporates elements of Molecular biology and Viral load.
Interleukin 21 is a subfield of Cytotoxic T cell that Rafick Pierre Sekaly studies.
He combines subjects such as Cell biology, IL-2 receptor, CCL5 and Antigen-presenting cell with his study of CD8.
His most cited work include:
- Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction (1242 citations)
- Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction (1242 citations)
- Skewed maturation of memory HIV-specific CD8 T lymphocytes (959 citations)
What are the main themes of his work throughout his whole career to date?
Rafick Pierre Sekaly mainly focuses on Immunology, Virology, T cell, Immune system and Cytotoxic T cell.
His research in Virology intersects with topics in Interleukin 2 and CTL*.
He works mostly in the field of Interleukin 2, limiting it down to concerns involving Interferon gamma and, occasionally, Interleukin.
His T cell study integrates concerns from other disciplines, such as Receptor, Peripheral blood mononuclear cell and Antigen.
While the research belongs to areas of Cytotoxic T cell, Rafick Pierre Sekaly spends his time largely on the problem of Cancer research, intersecting his research to questions surrounding Stem cell.
His Interleukin 21 study frequently links to other fields, such as IL-2 receptor.
He most often published in these fields:
- Immunology (78.87%)
- Virology (44.37%)
- T cell (40.14%)
What were the highlights of his more recent work (between 2013-2021)?
- Immunology (78.87%)
- Virology (44.37%)
- Immune system (29.58%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Virology, Immune system, Cancer research and Inflammation.
Rafick Pierre Sekaly combines topics linked to Cytotoxic T cell with his work on Immunology.
The study incorporates disciplines such as Proliferative capacity and Antigen in addition to Cytotoxic T cell.
His work on Viremia as part of general Virology research is frequently linked to Nonhuman primate, Cocaine use, Proviral dna and Heroin, bridging the gap between disciplines.
His Inflammation study which covers Pathogenesis that intersects with Macrophage and Interferon.
His study explores the link between Interleukin 21 and topics such as IL-2 receptor that cross with problems in CD28, Antigen-presenting cell and Natural killer T cell.
Between 2013 and 2021, his most popular works were:
- Normalizing the environment recapitulates adult human immune traits in laboratory mice (541 citations)
- CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART (191 citations)
- Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response (121 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Immunology, Immune system, Immunity, T cell and Virology.
Rafick Pierre Sekaly usually deals with Immunology and limits it to topics linked to Lymph and Cellular compartment.
His Immune system research is multidisciplinary, relying on both Specific-pathogen-free, Specific Pathogen Free Organism, Blood cell and Laboratory mouse.
He has included themes like Virus latency, Cytotoxic T cell and Cytokine in his T cell study.
His Cytokine research includes elements of Interleukin 12, Cell biology, IL-2 receptor and CD8.
His Interleukin 21 study is focused on Antigen in general.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
